Pursuant to Regulation 23(9) of SEBI(LODR) Regulations, 2015, we enclose herewith the disclosure of related party transactions for the half year ended 30.09.2025.
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kovai Medical Center and Hospital (KMCH) has filed its half-yearly related party transaction disclosure under SEBI LODR Regulation 23(9) for the period ended 30 September 2025, as required for H1 of FY26. Total value of related party transactions during the reporting period was approximately ₹7,220.69 lakhs. The largest transaction was the purchase of goods/services from Purani Hospital Supplies Private Limited (a director-related entity) at ₹4,835.78 lakhs, against an approved limit of ₹9,025 lakhs. Director remuneration was the next biggest component — Managing Director Dr. Nalla G Palaniswami received ₹827.16 lakhs, Joint MD Dr. Thavamani Devi Palaniswami received ₹815.29 lakhs, and Executive Director Dr. Arun N Palaniswami received ₹433.74 lakhs. Other notable items include lease rent of ₹114.20 lakhs paid to Dr. Thavamani Devi Palaniswami and ₹61.98 lakhs in purchases from NGP Estate Motors Agencies. All transactions were carried out at arm's length prices and approved by the audit committee, with most closing balances at zero except for small outstanding amounts in supplier transactions.
This is a routine compliance disclosure with no new material information. The transactions are within previously approved audit committee limits and at arm's length prices, indicating good governance. Shareholders can view this as a regulatory formality with no expected impact on the stock price.